Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001209191-23-026527

EVP and COO sold 342 shares at $9.88 ($3,378)

  • EVP and COO acquired 962 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Wolff Stefani · EVP and COO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-04-30 Exercise or conversion : show line 1 in the form +962 6,455 D
2023-05-01 Sale : show line 2 in the form −342 $9.88 $3,378 6,113 D
Open-market sales · 342 sh · avg $9.88 · $3,378

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-04-30 Exercise or conversion : show line 3 in the form Restricted Stock Units −962 10,582 D
Loading xslF345X04/doc4.xml…